Fabrication of a colorimetric approach for breast cancer detection using of DNAzyme based specific aptamers

Document Type : Original Research

Authors

1 Medical Genetic group, Kerman University of Medical Sciences, Kerman, Iran

2 Department of Biology, Faculty of sciences, Shahid Bahonar University of Kerman, Kerman, Iran

Abstract
Breast cancer is a serious health concern for women. It contributes to about 23% of the cancer cases, and accounts for the second largest number of deaths among all cancers. Expensive and time consuming recognition methods currently available for recognition of breast cancer potentiates the need for improvement of novel, specific and ultrasensitive strategies. Biosensors are sensitive, specific and cost effective procedures. These also display the benefit of quick response due to direct calculation in physiological fluids (saliva, blood, serum, milk, urine etc.) in a non-invasive way. Aptamer-based biosensors for cancer cell recognition have shown advantages of rapidness, simplicity and cost-efficiency over traditional approaches. In this study, by linking DNAzyme and aptamer together, we established colorimetric biosensor for the detection of MCF7 breast cancer cells. MUC1 and PTK7 aptamers used as specific aptamers to binding to the breast cancer cells. This manner may also evade the modification of DNA and the use of labels, which can intensely rise the cost-efficiency and simplicity of cancer cell discovery. Our results indicated that these aptamers showed good activity for breast cancer cells detection in which in the control cells no activity was observed. Results also indicated that there is a good linear relationship between the cancer cell values and colorimetric signal. Finally, the obtained results indicated a cost effective and conveniently operated approach for cancer diagnosis in future.

Keywords

Subjects


1. Nguyen NP, Almeida FS, Chi A, Nguyen LM, Cohen D, Karlsson U, Vinh-Hung V. Molecular biology of breast cancer stem cells: potential clinical applications. Cancer Treatment Reviews. 2010, 36(6), 485-91.
2. Videira M, Reis RL, Brito MA. Deconstructing breast cancer cell biology and the mechanisms of multidrug resistance. Biochimica et Biophysica Acta (BBA)-Reviews on Cancer. 2014,1846(2), 312-25.
3. Shangguan D., Cao Z., Meng L., Mallikaratchy P., Sefah K., Wang H., Li Y., Tan W., Cell-Specific Aptamer Probes for Membrane Protein Elucidation in Cancer Cells. J Proteome Res. 2008, 7(5): 2133–2139.
4. Mittal S., Kaur H., Gautam N., Manth A.K., Biosensors for breast cancer diagnosis:A review of bioreceptors, biotransducers an dsignal amplification strategies Biosensors and Bioelectronics, 2017, 88, 217–231
5. Padgett, J.K., Parlette, H.L., and English, J.C. A diagnosis of chronic lymphocytic leukemia prompted by cutaneous lymphocytic infiltrates present in mohs micrographic surgery frozen sections. Dermatol Surg. 2003, 29, 769–771.
6. Pan, C., Guo, M., Nie, Z., Xiao, X., and Yao, S. Aptamer based electrochemical sensor for label-free recognition and detection of cancer cells. Electroanalysis. 2009, 21, 1321–1326.
7. Baker, B.R., Lai, R.Y., Wood, M.S., Doctor, E.H., Heeger, A.J., and Plaxco, K.W. An electronic, aptamer-based small-molecule sensor for the rapid, label-free detection of cocaine in adulterated samples and biological fluids. J. Am. Chem. Soc, 2006, 128, 3138–3139.
8. Zhu X., Cao Y., Liang Z., Li G., Aptamer-based and DNAzyme-linked colorimetric detection of cancer cells, Protein Cell. 2010, 1(9): 842–846.
9. Degefa, T.H., Kwak, J. Label-free aptasensor for platelet derived growth factor (PDGF) protein. Anal Chim Acta, 2008, 613, 163–168.
10. Famulok, M., Mayer, G., and Blind, M. Nucleic acid aptamers from selection in vitro to applications in vivo. Acc. Chem. Res. 2000, 33, 591–599.
11. Ghossein, R.A., Bhattacharya, S. Molecular detection and characterisation of circulating tumour cells and micrometastases in solid tumours. Eur. J. Cancer, 2000, 36, 1681–1694.
12. Ferreira C. S. M., Papamichael K., Guilbault, G., Schwarzacher T., Gariepy J., Missailidis, S., DNA aptamers against the MUC1 tumour marker: design of aptamer–antibody sandwich ELISA for the early diagnosis of epithelial tumours Anal. Bioanal. Chem. 390, 2008, 1039–1050.
13. Ferreira, C.S.M., Matthews, C.S. Missailidis, S., DNA Aptamers That Bind to MUC1 Tumour Marker: Design and Characterization of MUC1-Binding Single-Stranded DNA Aptamers, Tumor Biol. 2006, 27, 289–301
14. Shangguan D., Li Y., Tang Z., Cao Z. C., Chen H. W., Mallikaratchy P., Sefah K., Yang C. J., Tan W., Aptamers evolved from live cells as effective molecular probes for cancer study, PNAS 8, 2006, 103, 32-38
15. Shi H., Li D., Xu F., He X., Wang K., Ye X., Tang J., He C., A label-free activatable aptamer probe for colorimetric detection of cancer cells based on binding-triggered in situ catalysis of split DNAzyme, Analyst, 2014, 139, 4181–4184
16. Florea A., Taleat Z., Cristea C., Mazloum-Ardakani M., Săndulescu R., Label free MUC1 aptasensors based on electrodeposition of gold nanoparticles on screen printed electrodes. Electrochemistry Communications, 2013, 33, 127–130.
17. Hu R., Wen W., Wang Q., Xiong H., Zhang X., Gu H., Wang S., Novel electrochemical aptamer biosensor based on an enzyme–gold nanoparticle duall abel for the ultrasensitive detection of epithelial tumour marker MUC1, Biosensors and Bioelectronics, 2014, 53, 384–389
18. Li T., Fan Q., Liu T., Zhu X., Zhao J., Li, G., Detection of breast cancer cells specially and accurately by an electrochemical method, Biosensors and Bioelectronics 25 (2010) 2686–2689.
19. Zhua X., Yangb J., Liua M., Wua Y., Shena Z., Li, G., Sensitive detection of human breast cancer cells based on aptamer–cell–aptamer sandwich architecture. Analytica Chimica Acta, 2013,764, 59–63.
20. He, F., Shen, Q., Jiang, H., Zhou, J., Cheng, J., Guo, D., Li, Q.,Wang, X., Fu, D., and Chen, B.. Rapid identification and high sensitive detection of cancer cells on the gold nanoparticle interface by combined contact angle and electrochemical measurements. Talanta 2009, 77, 1009–1014.
21. Zokaei E., Badoei-Dalfrad A., Ansari M., Karami Z., Eslaminejad T., and Nematollahi-Mahani, S.N. Therapeutic Potential of DNAzyme Loaded on Chitosan/Cyclodextrin Nanoparticle to Recovery of Chemosensitivity in the MCF-7 Cell Line. Applied Biochemistry and Biotechnology, 2019, 187 (3) 708-723.
22. Mahdiannasser, M., Karami, Z. An innovative paradigm of methods in microRNAs detection: highlighting DNAzymes, the illuminators. Biosensors and Bioelectronics, 2018, 107, 123-144.
23. Nikzad, N., Karami, Z. Label-free colorimetric sensor for sensitive detection of choline based on DNAzyme-choline oxidase coupling. International Journal of Biological Macromolecules, 2018, 115, 1241-1248.
24. Farrokhi, F., Karami, Z., Esmaeili-Mahani, S., Heydari, A. Delivery of DNAzyme targeting c-Myc gene using β-cyclodextrin polymer nanocarrier for therapeutic application in human breast cancer cell line, Journal of Drug Delivery Science and Technology, 2018, 47, 477-484.